Child GM1 Gangliosidosis – Case Report
DOI:
https://doi.org/10.5585/conssaude.v16n2.6976Keywords:
Gangliosidosis, Infantile, Ganglioside.Abstract
Introduction: Gangliosidosis is a disease characterized by accumulation of the ganglioside substrate in lysosomes due to beta-galactosidase enzyme deficiency. It is a rare disorder, with an incidence of 1: 100,000 to 200,000. Clinically the patients pres- ent varying degrees of neurodegeneration and skeletal changes, categorized by the gravity and residual activity of beta-galactosidase, being able to occur facial dysmorphism, hepatosplenomegaly, skeletal dysplasia, red macular spots, blind- ness and early death. Objectiv: Delayed neuropsychomotor development associated with degeneration of the central nervous system may lead the patient to progressive generalized muscular hypotonia, evolving into seizures and convulsive seizures. We report a case of male patient, presenting changes in neuropsychomotor devel- opment since eight months of age, with diagnostic elucidation through clinical exam, imaging and laboratory tests. Method: Search in digital databases for scientific articles that discuss gangliosidoses. Results/conclusion: Gangliosidosis is rare disorder, which makes reporting an important source of research.Downloads
Downloads
Published
2017-10-04
How to Cite
1.
Alquimim AF, Matos BP de, Antunes RVB, Cavalcanti LV, Santos TB dos, Atzingen AC von. Child GM1 Gangliosidosis – Case Report. Cons. Saúde [Internet]. 2017 Oct. 4 [cited 2025 Jun. 20];16(2):289-92. Available from: https://periodicos.uninove.br/saude/article/view/6976
Issue
Section
Cases studies
License
Copyright (c) 2017 ConScientiae Saúde

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Views
- Abstract 631
- PDF (Português (Brasil)) 343